X
skip to main content
Logo
  • January 04, 2017

    A biomarker study by COEUR (Canadian Ovarian Experimental Unified Resource), TFRI’s pan-Canadian ovarian cancer research team, examining over 2,000 ovarian cancer tissue samples has led to the development of an inexpensive immunohistochemical algorithm for classifying the five different disease subtypes.

  • January 04, 2017

    Awards to three New Investigators were made by TFRI in late December 2016, for a total investment of $1.3 million. Each award is valued at $450,000 for a term of three years, commencing Jan. 1, 2017. Recipients are: Dr. Housheng Hansen He (UHN), Dr. Frédérick Mallette (UdeM), and Dr. Peter Stirling (BC Cancer Agency).

  • January 03, 2017

  • January 03, 2017

  • January 03, 2017

  • January 03, 2017

  • January 03, 2017

Back to Top